CLINICAL-PHARMACOLOGY OF INTRAMUSCULARLY ADMINISTERED L-ASPARAGINASE

被引：22

作者：

HO, DHW ^{[1
]}

YAP, HY ^{[1
]}

BROWN, N ^{[1
]}

BENJAMIN, RS ^{[1
]}

FRIEREICH, EJ ^{[1
]}

BLUMENSCHEIN, GR ^{[1
]}

BODEY, GP ^{[1
]}

机构：

[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT MED,HOUSTON,TX 77030

来源：

关键词：

D O I：

10.1002/j.1552-4604.1981.tb01752.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：72 / 78

页数：7

共 23 条

[1] ALTMAN PL, 1961, BLOOD OTHER BODY FLU, P2
[2] BIOZZI G, 1953, BRIT J EXP PATHOL, V34, P441
[3] EVIDENCE THAT L-ASPARAGINASE ACTIVITY OF GUINEA PIG SERUM IS RESPONSIBLE FOR ITS ANTILYMPHOMA EFFECTS
BROOME, JD
[J]. NATURE, 1961, 191 (479) : 1114 - &
[4] FACTORS WHICH MAY INFLUENCE EFFECTIVENESS OF L-ASPARAGINASES AS TUMOR INHIBITORS
BROOME, JD
[J]. BRITISH JOURNAL OF CANCER, 1968, 22 (03) : 595 - &
[5] FLEISHER GA, 1963, J LAB CLIN MED, V61, P98
[6] HARRIS RE, 1978, AM SOC CLIN ONCOL, V19, P328
[7] L-ASPARAGINASE THERAPY FOR LEUKEMIA AND OTHER MALIGNANT NEOPLASMS - REMISSION IN HUMAN LEUKEMIA
HILL, JM
ROBERTS, J
LOEB, E
KHAN, A
MACLELLAN, A
HILL, RW
[J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1967, 202 (09) : 882 - +
[8] HO DHW, 1971, CANCER CHEMOTH REP 1, V55, P539
[9] LEVY G, 1968, IMPORTANCE FUNDAMENT, P148
[10] LOBEL J, 1978, AM SOC CLIN ONCOL, V19, P383